Skip to main content

Table 1 Antimicrobial susceptibility of S. pneumoniae isolated from children with CAP

From: Molecular epidemiology of Streptococcus pneumoniae isolated from pediatric community-acquired pneumonia in pre-conjugate vaccine era in Western China

Antibiotic

CC271 n (%) (n = 182)

Non-CC271 n (%) (n = 237)

Total n (%) (n = 419)

χ2

P

R

S

R

S

R

S

Penicillin Parenterala

5 (2.7)

177 (97.3)

1 (0.4)

236 (99.6)

6 (1.5)

413 (98.5)

2.47

0.116

Vancomycin

0 (0.0)

182 (100.0)

0 (0.0)

237 (100.0)

0 (0.0)

419 (100.0)

–

–

Erythromycin

175 (96.2)

7 (3.8)

220 (92.8)

17 (7.2)

395 (94.3)

24 (5.7)

2.11

0.146

Levofloxacin

2 (1.1)

180 (98.9)

2 (0.8)

235 (99.2)

415 (99.0)

4 (1.0)

0.00

1.000

Tetracycline

169 (92.9)

13 (7.1)

200 (84.4)

37 (15.6)

368 (87.8)

51 (12.2)

7.03

0.008

Trimethoprim-sulfamethoxazole

167 (91.8)

15 (8.2)

202 (85.2)

35 (14.8)

369 (88.1)

50 (11.9)

4.17

0.041

Linezolid

15 (8.2)

167 (91.8)

20 (8.4)

217 (91.6)

35 (8.4)

384 (91.6)

0.01

0.942

Clindamycin

177 (97.3)

5 (2.7)

220 (92.8)

17 (7.2)

397 (94.7)

22 (5.3)

4.05

0.044

Chloramphenicol

7 (3.8)

175 (96.2)

14 (5.9)

223 (94.1)

21 (5.0)

398 (95.0)

0.92

0.338

Cefotaximea

81 (44.5)

101 (55.5)

39 (16.5)

198 (83.5)

120 (28.6)

299 (71.4)

39.63

 < 0.001

  1. Italic values indicate significance of P value (P < 0.05)
  2. CAP: community-acquired pneumonia
  3. a2016 CLSI breakpoints were considered for non-meningitis